Clinical Trials
538 trialsCHRU-WCMC
University Hospital, Lille
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
Jonsson Comprehensive Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
QUANTIB
IRCCS San Raffaele
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
RF-2018-123683
IRCCS San Raffaele
MP-PET-MRI
IRCCS San Raffaele
PRS-AS
IRCCS San Raffaele
EVENTIDE
University of Aberdeen
PSMA-MRI BX
Fatih Sultan Mehmet Training and Research Hospital
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
PROSTED
Centre Hospitalier Universitaire de NÄ«mes
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Yale University
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
Institut du Cancer de Montpellier - Val d'Aurelle
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
HoSAGE
Assistance Publique Hopitaux De Marseille
Exploring Men s Prostate Cancer Genetic Risk Perceptions
H. Lee Moffitt Cancer Center and Research Institute
Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy
Martini-Klinik am UKE GmbH
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
PRISME
Ipsen
Microarray Analysis of Gene Expression in Prostate Tissues
Stanford University
Prostate Cancer Upgrading Reference Set
The University of Texas Health Science Center at San Antonio
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients
Ohio State University Comprehensive Cancer Center
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
QUADO
Central Hospital, Nancy, France
BARVANA LONG
Aesculap AG
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
IMPLICATION
Centre Hospitalier Universitaire de Besancon
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Pfizer
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Pfizer
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Biobank for African American Prostate Cancer Research in Florida
H. Lee Moffitt Cancer Center and Research Institute
Periop ctDNA
Centre Hospitalier Universitaire de NÄ«mes
Effect of Changes in Endotracheal Tube Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Robotic Surgery
Ege University
EPICAP-QALY
Centre Hospitalier Universitaire de NÄ«mes
PROSTA-PAP
Assistance Publique - Hôpitaux de Paris
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
AstraZeneca
Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation
Karolinska Institutet
PER2PSMA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
BP-008
BioProtect
CLP-10095
BioProtect
ARPC-MRI
East and North Hertfordshire NHS Trust